The COVID-19 lockdown brought unexpected sugar control wins for type 1 diabetes patients through less stress, steady routines, and telemedicine care, but would those gains fade after restrictions lifted? 
In a study published in the Diabetology and Metabolic Syndrome, the researchers followed 207 adults with type 1 diabetes (average age 38 years, half on multiple daily shots and half on insulin pumps). They tracked continuous glucose monitor data like time in range from 70 to 180 mg/dl, time above 250, time below 54, and sugar swings through coefficient of variation. Checks happened before lockdown, during it, and at six, 12, and 24 months after. Patients also filled online forms about eating, exercise, and habits before, during, and one year post-lockdown. This real-world look reveals what stuck.
Sugar Targets Hold Strong for Years
Improvements seen during lockdown did not disappear. Time in target range stayed significantly higher at every check after—six months, one year, and two years—all with P under 0.05. Time above 250 mg/dl dropped and stayed low, while dangerous lows under 54 mg/dl also remained reduced across all points.
Lifestyle Stays Same, Not the Key Driver
One year after lockdown, eating and activity habits matched pre-pandemic levels with little change. Daily life bounced back without big shifts that could explain the lasting sugar wins.
Tech Upgrades Power the Long Win
Telemedicine became the main care method during this time, smoothing check-ins without office visits. The real game-changer showed in patients who switched to advanced insulin delivery like pumps or automated systems during the two years—their control soared with P under 0.001.
Guide for Type 1 Diabetes Care Teams
Endocrinologists see proof that pandemic lessons like home tech and virtual visits work, but upgrading pumps locks in gains best. Push early switches for steady patients to keep sugars tight long-term.